Hepatitis C virus infection and chronic kidney disease: time for reappraisal

P Cacoub, AC Desbois, C Isnard-Bagnis… - Journal of …, 2016 - Elsevier
Hepatitis C virus (HCV) infection is associated with tremendous morbidity and mortality due
to liver complications. HCV infection is also associated with many extrahepatic …

Hepatitis C and its impact on renal transplantation

JM Morales, F Fabrizi - Nature Reviews Nephrology, 2015 - nature.com
Infection with hepatitis C virus (HCV) is the major cause of chronic liver disease that occurs
after renal transplantation. Such infection is often acquired during dialysis while patients wait …

Viral hepatitis: guidelines by the American society of transplantation infectious disease community of practice

H Te, K Doucette - Clinical transplantation, 2019 - Wiley Online Library
These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection

E Lawitz, R Flisiak, M Abunimeh, ME Sise… - Liver …, 2020 - Wiley Online Library
Abstract Background and Aims Chronic hepatitis C virus (HCV) infection increases the risk of
incident chronic kidney disease (CKD) and progression to end‐stage renal disease (ESRD) …

[HTML][HTML] Hepatitis C virus infection and kidney transplantation in 2014: what's new?

S Baid-Agrawal, M Pascual, D Moradpour… - American journal of …, 2014 - Elsevier
Chronic hepatitis C virus (HCV) infection remains an important health problem, which is
associated with deleterious consequences in kidney transplant recipients. Besides hepatic …

Safety and efficacy of treatment of hepatitis C in kidney transplant recipients with directly acting antiviral agents

M Lubetzky, S Chun, A Joelson, M Coco, L Kamal… - …, 2017 - journals.lww.com
Background With the development of all oral, interferon-free directly acting antiviral (DAA)
medications, treatment of hepatitis C virus (HCV) infection in renal transplant recipients is …

Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5

CH Liu, JH Kao - Hepatology international, 2022 - Springer
Hepatitis C virus (HCV) infection is a major health problem with significant clinical and
economic burdens in patients with chronic kidney disease (CKD) stage 4 or 5. Current …

Hepatitis C virus and nonliver solid organ transplantation

M Carbone, D Mutimer, J Neuberger - Transplantation, 2013 - journals.lww.com
Hepatitis C virus (HCV) infection is common in solid organ allograft recipients and is a
significant cause of morbidity and mortality after transplantation, so effective management …

Global prevalence of occult hepatitis C virus: a systematic review and meta-analysis

DS Mbaga, S Kenmoe, JN Bikoï… - World Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
BACKGROUND Occult hepatitis C infection (OCI) is characterized by the presence of
hepatitis C virus (HCV) RNA in the liver, peripheral blood mononuclear cells (PBMC) and/or …

Management of hepatitis C in patients with chronic kidney disease

RJ Carvalho-Filho, ACCA Feldner… - World journal of …, 2015 - pmc.ncbi.nlm.nih.gov
Hepatitis C virus (HCV) infection is highly prevalent among chronic kidney disease (CKD)
subjects under hemodialysis and in kidney transplantation (KT) recipients, being an …